These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12506631)

  • 1. [Immunobiological properties of Burkholderia pseudomallei and Burkholderia mallei capsular substances].
    Popov SF; Tikhonov NG; Piven' NN; Avrorova IV; Viktorov DV; Kurilov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):60-4. PubMed ID: 12506631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
    Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
    Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.
    Tiyawisutsri R; Holden MT; Tumapa S; Rengpipat S; Clarke SR; Foster SJ; Nierman WC; Day NP; Peacock SJ
    BMC Microbiol; 2007 Mar; 7():19. PubMed ID: 17362501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
    Popov SF; Kurilov VIa; Iakovlev AT
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic relatedness between Burkholderia pseudomallei and Burkholderia mallei.
    Anuntagool N; Sirisinha S
    Microbiol Immunol; 2002; 46(3):143-50. PubMed ID: 12008922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of extracellular antigens by immunodiffusion methods in differentiation of pathogenic burkholderiae].
    Budchenko AA; Mazurova IIu; Iliukhin VI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (1):54-60. PubMed ID: 22442972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis.
    Ngugi SA; Ventura VV; Qazi O; Harding SV; Kitto GB; Estes DM; Dell A; Titball RW; Atkins TP; Brown KA; Hitchen PG; Prior JL
    Vaccine; 2010 Nov; 28(47):7551-5. PubMed ID: 20837078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 12. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.
    Godoy D; Randle G; Simpson AJ; Aanensen DM; Pitt TL; Kinoshita R; Spratt BG
    J Clin Microbiol; 2003 May; 41(5):2068-79. PubMed ID: 12734250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ultrastructural immunochemical study of pathogenic Burkholderia capsule].
    Piven' NN; Alekseev VV; Popov SF; Khrapova NP; Prokhvatilova EV; Viktorov DV; Plekhanova NG; Kapliev VI; Avrorova IV
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):19-24. PubMed ID: 16279528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei.
    Larsen JC; Johnson NH
    Mil Med; 2009 Jun; 174(6):647-51. PubMed ID: 19585782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?
    Titball RW; Burtnick MN; Bancroft GJ; Brett P
    Vaccine; 2017 Oct; 35(44):5981-5989. PubMed ID: 28336210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a latex agglutination assay for the identification of Burkholderia pseudomallei and Burkholderia mallei.
    Duval BD; Elrod MG; Gee JE; Chantratita N; Tandhavanant S; Limmathurotsakul D; Hoffmaster AR
    Am J Trop Med Hyg; 2014 Jun; 90(6):1043-6. PubMed ID: 24710616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
    Galyov EE; Brett PJ; DeShazer D
    Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exopolysaccharides of Burkholderia pseudomallei.
    Steinmetz I; Nimtz M; Wray V; Häussler S; Reganzerowski A; Brenneke B
    Acta Trop; 2000 Feb; 74(2-3):211-4. PubMed ID: 10674651
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
    Parthasarathy N; DeShazer D; England M; Waag DM
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):329-32. PubMed ID: 16765554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.